Companies /Industrials

CryoPort Inc

NASDAQ: CYRX Integrated Freight & Logistics
$19.05
▼ $0.50 (−2.56%) today
Markets closed · 10:26am ET

CYRX at a Glance

Valuation
Market cap
$964.9M
Profitability
Revenue (TTM)
$192.4M
Profit margin
-21.5%
EPS (TTM)
$-0.90
Price
52-week range
$8 – $22
Street target
$22.33

Headquartered in Brentwood, TN Fiscal year ends December NASDAQ: CYRX cryoportinc.com

About Cryoport

Cryoport, Inc. provides integrated temperature-controlled supply chain solutions for the life sciences, with an emphasis on regenerative medicine and cell and gene therapies (CGT). Its customers include biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers and researchers.

The company reports two segments:
- **Life Sciences Services** (about 57% of Q3 2026 revenue) includes BioLogistics Solutions and BioStorage/BioServices. These cover the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized logistics, storage, and cryopreservation services. Delivery runs through a Global Supply Chain Center Network, including Santa Ana, California and Paris, France, and through CRYOGENE.
- **Life Sciences Products** (about 43%) consists mainly of cryogenic systems sold by MVE Biological Solutions.

As of September 30, 2026, Cryoport supported 23 commercially approved cell and gene therapies and 788 clinical trials across the Americas, EMEA and APAC. It sold its CRYOPDP specialty courier business to DHL Group in June 2025, and that business is now reported as discontinued operations. Updated

CYRX Coverage

Frequently Asked Questions

What does Cryoport do?

Cryoport, Inc. provides integrated temperature-controlled supply chain solutions for the life sciences, with an emphasis on regenerative medicine and cell and gene therapies (CGT).

What is the CYRX stock price target?

The Wall Street consensus 12-month price target for CYRX is $22.33.